{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:53:04Z","timestamp":1793040784236,"version":"4.5.0"},"reference-count":65,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Oncotelic Therapeutics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) and pancreatic ductal adenocarcinoma (PDAC) are highly lethal cancers marked by profound epigenetic and metabolic reprogramming. Among the candidate biomarkers, the DNA methyltransferase DNMT3A and the guanine monophosphate synthetase (GMPS) have emerged as potential prognostic drivers, yet their roles across tumor contexts remain unclear. Here, we demonstrate the application of KMplotter to interrogated pan-cancer transcriptomic and survival datasets encompassing over 7000 patients, complemented by expression profiling of normal, tumor, and metastatic tissues, and integrated tumor microenvironment (TME) analyses. Elevated DNMT3A and GMPS expression correlated with worse overall survival in HCC, particularly in Asian patients, while in PDAC, high DNMT3A but low GMPS expression predicted favorable outcomes. Both genes were consistently upregulated in tumors relative to normal tissues, with further increases in metastatic HCC. Immune deconvolution revealed that DNMT3A was linked to Th2\/Treg-enriched niches, whereas GMPS overexpression coincided with high mutational burden or stromal enrichment, fostering immunosuppressive microenvironments. Comparative analysis of toll-like receptor signatures highlighted divergent antigen-sensing pathways, with HCC reflecting viral-driven immune exhaustion and PDAC showing self-antigen\u2013associated signaling. Collectively, these findings position DNMT3A and GMPS as context-dependent biomarkers that integrate metabolic and immune cues to shape prognosis in liver and pancreatic cancer, offering mechanistic insight and translational relevance for patient stratification.<\/jats:p>","DOI":"10.3390\/ijms262411920","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:32:17Z","timestamp":1765380737000},"page":"11920","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter"],"prefix":"10.3390","volume":"26","author":[{"given":"Wen-Han","family":"Chang","sequence":"first","affiliation":[{"name":"Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drashya","family":"Shah","sequence":"additional","affiliation":[{"name":"Brush and Key Foundation, 4003 Jim Bowie, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Myers","sequence":"additional","affiliation":[{"name":"Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Potts","sequence":"additional","affiliation":[{"name":"Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjive","family":"Qazi","sequence":"additional","affiliation":[{"name":"Oncotelic Therapeutics, 29397 Agoura Road, Suite 107, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-0811","authenticated-orcid":false,"given":"Vuong","family":"Trieu","sequence":"additional","affiliation":[{"name":"Brush and Key Foundation, 4003 Jim Bowie, Agoura Hills, CA 91301, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Guo, H., Lu, F., Lu, R., Huang, M., Li, X., Yuan, J., and Wang, F. (2023). A novel tumor 4-driver gene signature for the prognosis of hepatocellular carcinoma. Heliyon, 9.","DOI":"10.1016\/j.heliyon.2023.e17054"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.27200","article-title":"Modulation of miR-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome","volume":"60","author":"Parpart","year":"2014","journal-title":"Hepatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"102048","DOI":"10.1016\/j.tranon.2024.102048","article-title":"Therapeutic potential of tLyp-1-EV-shCTCF in inhibiting liver cancer stem cell self-renewal and immune escape via SALL3 modulation in hepatocellular carcinoma","volume":"49","author":"Zhu","year":"2024","journal-title":"Transl. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101340","DOI":"10.1016\/j.jhepr.2025.101340","article-title":"Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis","volume":"7","author":"Schulze","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_5","first-page":"4238","article-title":"Genome-wide hypomethylation in hepatocellular carcinogenesis","volume":"61","author":"Lin","year":"2001","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3892\/ol.2021.13140","article-title":"Direct molecular evidence for both multicentric and monoclonal carcinogenesis followed by transdifferentiation from hepatocellular carcinoma to cholangiocarcinoma in a case of metachronous liver cancer","volume":"23","author":"Ohni","year":"2022","journal-title":"Oncol. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.2174\/0109298673359092250304031435","article-title":"Machine Learning-based Gene Biomarker Identification for Improving Prognosis and Therapy in Hepatocellular Carcinoma","volume":"32","author":"Deng","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12032-017-0963-9","article-title":"The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data","volume":"34","author":"Zhang","year":"2017","journal-title":"Med. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.3748\/wjg.v17.i44.4853","article-title":"Hepatitis B virus infection and the risk of hepatocellular carcinoma","volume":"17","author":"Tan","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11630","DOI":"10.3748\/wjg.v20.i33.11630","article-title":"Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis","volume":"20","author":"Tarocchi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tian, Z., Xu, C., Yang, P., Lin, Z., Wu, W., Zhang, W., Ding, J., Ding, R., Zhang, X., and Dou, K. (2022). Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.984728"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2174\/1566524033479546","article-title":"Mechanisms of human hepatocarcinogenesis","volume":"3","author":"Coleman","year":"2003","journal-title":"Curr. Mol. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.nbt.2013.01.007","article-title":"Genetics and epigenetics of liver cancer","volume":"30","author":"Ozen","year":"2013","journal-title":"N. Biotechnol."},{"key":"ref_15","first-page":"19","article-title":"Burden of gastrointestinal cancer in Asia; an overview","volume":"8","author":"Pourhoseingholi","year":"2015","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpg.2004.11.005","article-title":"Molecular mechanisms in hepatocellular carcinoma development","volume":"19","author":"Cha","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/jhep.2001.22507","article-title":"Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis","volume":"33","author":"Saito","year":"2001","journal-title":"Hepatology"},{"key":"ref_18","first-page":"65","article-title":"DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation","volume":"20","author":"Oh","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.31557\/APJCP.2020.21.11.3357","article-title":"DNA Methyltransferases as Potential Biomarkers for HCV Related Hepatocellular Carcinoma","volume":"21","author":"Hassouna","year":"2020","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/hupa.2003.5","article-title":"Expression of DNA methyltransferases in multistep hepatocarcinogenesis","volume":"34","author":"Choi","year":"2003","journal-title":"Hum. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"737535","DOI":"10.1155\/2010\/737535","article-title":"Depletion of DNMT3A suppressed cell proliferation and restored PTEN in hepatocellular carcinoma cell","volume":"2010","author":"Zhao","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.14715\/cmb\/2023.69.9.8","article-title":"High expression of DNMT3A and DNMT3B regulatory factors of TGFB in non-neoplastic liver tissues of HCC","volume":"69","author":"Hu","year":"2023","journal-title":"Cell. Mol. Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"148958","DOI":"10.1016\/j.gene.2024.148958","article-title":"Integrated GMPS and RAMP3 as a signature to predict prognosis and immune heterogeneity in hepatocellular carcinoma","volume":"933","author":"Chen","year":"2025","journal-title":"Gene"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10487","DOI":"10.1007\/s13277-016-4941-1","article-title":"DNA methyltransferase 1, 3a, and 3b expression in hepatitis C associated human hepatocellular carcinoma and their clinicopathological association","volume":"37","author":"Siddiqui","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6379","DOI":"10.2147\/CMAR.S201610","article-title":"DNMT3a promotes proliferation by activating the STAT3 signaling pathway and depressing apoptosis in pancreatic cancer","volume":"11","author":"Jing","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1158\/2159-8290.CD-22-0200","article-title":"Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer","volume":"12","author":"Anurag","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20087","DOI":"10.1073\/pnas.1909849116","article-title":"Genetic variation of DNA methyltransferase-3A contributes to protection against persistent MRSA bacteremia in patients","volume":"116","author":"Ruffin","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41392-021-00769-z","article-title":"Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.canlet.2005.03.017","article-title":"DNA methyltransferase expression and DNA hypermethylation in human hepatocellular carcinoma","volume":"233","author":"Park","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41418-024-01432-0","article-title":"A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma","volume":"32","author":"Guo","year":"2025","journal-title":"Cell Death Differ."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zhang, J., Zhang, X., Wu, R., and Dong, C.S. (2025). Unveiling purine metabolism dysregulation orchestrated immunosuppression in advanced pancreatic cancer and concentrating on the central role of NT5E. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1569088"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molmet.2019.02.006","article-title":"Dysregulated transmethylation leading to hepatocellular carcinoma compromises redox homeostasis and glucose formation","volume":"23","author":"Hughey","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-018-0913-y","article-title":"Effects of tumor metabolic microenvironment on regulatory T cells","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13045-022-01322-3","article-title":"Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: Implications for antitumor immunity","volume":"15","author":"Yan","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/s12967-023-04323-z","article-title":"DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming","volume":"21","author":"Yang","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Song, W., Yu, Y., Wang, S., Cui, Z., Zhu, Q., Liu, W., Wei, S., and Chi, J. (2025). Metabolic reprogramming shapes the immune microenvironment in pancreatic adenocarcinoma: Prognostic implications and therapeutic targets. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1555287"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1158\/0008-5472.CAN-16-1765","article-title":"Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment","volume":"77","author":"Delitto","year":"2017","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1172\/JCI63606","article-title":"Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans","volume":"122","author":"Ochi","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/1078-0432.CCR-15-1732","article-title":"Systemic Immune Activity Predicts Overall Survival in Treatment-Naive Patients with Metastatic Pancreatic Cancer","volume":"22","author":"Farren","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2024.05.005","article-title":"Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma","volume":"271","author":"Tomasich","year":"2024","journal-title":"Transl. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-3-319-09614-8_8","article-title":"TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis","volume":"815","author":"Machida","year":"2015","journal-title":"Biological Basis of Alcohol-Induced Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3748\/wjg.v24.i25.2733","article-title":"Transforming growth factor-beta and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma","volume":"24","author":"An","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.cmet.2021.09.002","article-title":"Tumor-derived exosomes drive immunosuppressive macrophages in a pre-metastatic niche through glycolytic dominant metabolic reprogramming","volume":"33","author":"Morrissey","year":"2021","journal-title":"Cell Metab."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Jin, X., Zhang, N., Yan, T., Wei, J., Hao, L., Sun, C., Zhao, H., and Jiang, S. (2025). Lactate-mediated metabolic reprogramming of tumor-associated macrophages: Implications for tumor progression and therapeutic potential. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1573039"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e1031","DOI":"10.1093\/oncolo\/oyad113","article-title":"Association of Tumor Cell Metabolic Subtype and Immune Response with the Clinical Course of Hepatocellular Carcinoma","volume":"28","author":"Wei","year":"2023","journal-title":"Oncologist"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Yang, J., Zeng, L., Chen, R., Zheng, S., Zhou, Y., and Chen, R. (2023). Characterization of heterogeneous metabolism in hepatocellular carcinoma identifies new therapeutic target and treatment strategy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1076587"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Beilmann-Lehtonen, I., Kasurinen, J., Hagstrom, J., Kaprio, T., Bockelman, C., and Haglund, C. (2023). High tissue expression of TLRs combined with high density of tumor infiltrating lymphocytes predicts a better prognosis in colorectal cancer patients. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0280085"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1479-5876-8-112","article-title":"The tumor microenvironment of colorectal cancer: Stromal TLR-4 expression as a potential prognostic marker","volume":"8","author":"Cammarota","year":"2010","journal-title":"J. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12553","DOI":"10.1038\/s41598-019-49111-2","article-title":"Evaluation of toll-like receptors as prognostic biomarkers in gastric cancer: High tissue TLR5 predicts a better outcome","volume":"9","author":"Kasurinen","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00428-017-2087-1","article-title":"High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients","volume":"470","author":"Leppanen","year":"2017","journal-title":"Virchows Arch."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1158\/1078-0432.CCR-12-0408","article-title":"Molecular pathways: Toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity","volume":"19","author":"Ridnour","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2174\/138161210790963779","article-title":"Toll-like receptors: Cost or benefit for cancer?","volume":"16","author":"Matijevic","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e0153123","DOI":"10.1128\/mbio.01531-23","article-title":"Comparison of Helicobacter pylori positive and negative gastric cancer via multi-omics analysis","volume":"14","author":"Shang","year":"2023","journal-title":"mBio"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Bednarz-Misa, I., Fortuna, P., Diakowska, D., Jamrozik, N., and Krzystek-Korpacka, M. (2020). Distinct Local and Systemic Molecular Signatures in the Esophageal and Gastric Cancers: Possible Therapy Targets and Biomarkers for Gastric Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124509"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_57","first-page":"100625","article-title":"Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors","volume":"5","author":"Gyorffy","year":"2024","journal-title":"Innovation"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.1111\/bph.70215","article-title":"Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets","volume":"182","author":"Posta","year":"2025","journal-title":"Br. J. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","article-title":"Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer","volume":"45","author":"Gyorffy","year":"2023","journal-title":"GeroScience"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bph.16257","article-title":"Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer","volume":"181","author":"Gyorffy","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"181006","DOI":"10.1098\/rsos.181006","article-title":"Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma","volume":"5","author":"Menyhart","year":"2018","journal-title":"R. Soc. Open Sci."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/cts.13563","article-title":"Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors","volume":"16","author":"Posta","year":"2023","journal-title":"Clin. Transl. Sci."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bartha, A., and Gyorffy, B. (2021). TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052622"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets with tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"bbaa219","DOI":"10.1093\/bib\/bbaa219","article-title":"A review of digital cytometry methods: Estimating the relative abundance of cell types in a bulk of cells","volume":"22","author":"Le","year":"2021","journal-title":"Brief. Bioinform."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11920\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T15:35:52Z","timestamp":1765380952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/24\/11920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":65,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262411920"],"URL":"https:\/\/doi.org\/10.3390\/ijms262411920","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}